Cite
Platinum resistant recurrence and early recurrence in a multi-centre cohort of patients undergoing interval cytoreductive surgery for advanced epithelial ovarian cancer.
MLA
Bhatt, Aditi, et al. “Platinum Resistant Recurrence and Early Recurrence in a Multi-Centre Cohort of Patients Undergoing Interval Cytoreductive Surgery for Advanced Epithelial Ovarian Cancer.” Frontiers in Oncology, vol. 12, Sept. 2022, p. 951419. EBSCOhost, https://doi.org/10.3389/fonc.2022.951419.
APA
Bhatt, A., Sinukumar, S., Kepenekian, V., Kammar, P., Mehta, S., Shaikh, S., Gertych, W., Bakrin, N., & Glehen, O. (2022). Platinum resistant recurrence and early recurrence in a multi-centre cohort of patients undergoing interval cytoreductive surgery for advanced epithelial ovarian cancer. Frontiers in Oncology, 12, 951419. https://doi.org/10.3389/fonc.2022.951419
Chicago
Bhatt, Aditi, Snita Sinukumar, Vahan Kepenekian, Praveen Kammar, Sanket Mehta, Sakina Shaikh, Witold Gertych, Naoual Bakrin, and Olivier Glehen. 2022. “Platinum Resistant Recurrence and Early Recurrence in a Multi-Centre Cohort of Patients Undergoing Interval Cytoreductive Surgery for Advanced Epithelial Ovarian Cancer.” Frontiers in Oncology 12 (September): 951419. doi:10.3389/fonc.2022.951419.